| 英文别名 |
norfloxacin;1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylica;1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid;Norfloxacine;1-ethyl-6-fluoro-4-oxo-7-piperazinyl-1,4-dihydro-quinoline-3-carboxylic acid;1-ethyl-6-fluoro-7-piperazino-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid;4803P;am-715;Barazan;Fulgram;GMP;Noflo;noroxin;Utinor;WAKO149-08241;Zomxin;Zoroxin;1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid;Baccidal;Chibroxin;Floxacin 400;Norphloxacine;N-Desmethylpefloxacin;Sebercim;Norfloxacinum;Norfloxacino;Lexinor;NFLX;Norfloxacine [INN-French];1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid;Norfloxacinum [INN-Latin];Norfloxacino [INN-Spanish];AM 715;MK 0366;1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxy;MK-0366;Norfloxacin for system suitability;Norfloxacin for peak identification;7-(1-Piperazinyl)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;7-(1-Piperazinyl)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;KBio3_001607;KBio3_001607;Spectrum3_000524;Spectrum3_000524;BRN 0567897;BRN 0567897;NCGC00021725-03;NCGC00021725-03;Norfloxacin (USAN:USP:INN:BAN:JAN);Norfloxacin (USAN:USP:INN:BAN:JAN);GTPL12408;GTPL12408;NCGC00016916-01;NCGC00016916-01;NCGC00016916-03;NCGC00016916-03;1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;DTXSID7037680;DTXSID7037680;J01MA06;J01MA06;CS-1906;CS-1906;NORFLOXACIN (MART.);NORFLOXACIN (MART.);NORFLOXACIN (EP MONOGRAPH);NORFLOXACIN (EP MONOGRAPH);AM-715;AM-715;NORFLOXACIN [JAN];NORFLOXACIN [JAN];CCG-40235;CCG-40235;BRD-K11196887-001-22-0;BRD-K11196887-001-22-0;C06687;C06687;1-ethyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid;1-ethyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid;BRD-K11196887-001-05-5;BRD-K11196887-001-05-5;BIDD:GT0725;BIDD:GT0725;NORFLOXACIN [ORANGE BOOK];NORFLOXACIN [ORANGE BOOK];Norfloxacin (Norxacin);Norfloxacin (Norxacin);NORFLOXACIN [USP-RS];NORFLOXACIN [USP-RS];KBio2_001497;KBio2_001497;BDBM50045000;BDBM50045000;NCGC00016916-06;NCGC00016916-06;Norfloxacin, Antibiotic for Culture Media Use Only;Norfloxacin, Antibiotic for Culture Media Use Only;KBioGR_000866;KBioGR_000866;PEFLOXACINE_met009;PEFLOXACINE_met009;Oprea1_375152;Oprea1_375152;HMS2235G03;HMS2235G03;Spectrum4_000453;Spectrum4_000453;Norfloxacin, British Pharmacopoeia (BP) Reference Standard;Norfloxacin, British Pharmacopoeia (BP) Reference Standard;EN300-06467;EN300-06467;Epitope ID:119068;Epitope ID:119068;Noroxin (TN);Noroxin (TN);Norfloxacin, European Pharmacopoeia (EP) Reference Standard;Norfloxacin, European Pharmacopoeia (EP) Reference Standard;HMS2091J16;HMS2091J16;AKOS000417391;AKOS000417391;Tox21_1106... |